Back
Protagonist Therapeutics Stock Price Chart
Sponsored
Make The SMART Move and Get The Inflation Survival Plan!
So don't wait until it's too late, act now and secure your future TODAY!
Sell
41
PTGX
Protagonist Therapeutics
Last Price:
22.44
Seasonality Move:
22.79%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Secure Your Family's Future in 15 Seconds With Gold-IRA
Take 15 Seconds to get the FREE Inflation Survival Plan and ensure your family's financial security.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.68 | Buy |
| 20-day SMA: | 21.83 | Buy |
| 50-day SMA: | 17.59 | Buy |
| 200-day SMA: | 11.19 | Buy |
| 8-day EMA: | 21.79 | Buy |
| 20-day EMA: | 21.14 | Buy |
| 50-day EMA: | 18.21 | Buy |
| 200-day EMA: | 14.61 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 59.37 | Buy |
| Chaikin Money Flow: | 693506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.21 - 24.21) | Buy |
| Bollinger Bands (100): | (8.1 - 18.64) | Buy |
Protagonist Therapeutics Technical Analysis
| Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | Mar-27 | Mar-28 | Mar-29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 22.34 while PTGX 8-day simple moving average is 21.68, which is a Buy signal.
- The stock price of PTGX is 22.34 while Protagonist Therapeutics 20-day SMA is 21.83, which makes it a Buy.
- Protagonist Therapeutics 50-day simple moving average is 17.59 while PTGX share price is 22.34, making it a Buy technically.
- PTGX stock price is 22.34 and Protagonist Therapeutics 200-day simple moving average is 11.19, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
41
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $22.34. The Score for PTGX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
1.15B
Price in USD:
22.34
Share Volume:
731.77K
Protagonist Therapeutics 52-Week Range
52-Week High:
25.76
52-Week Low:
6.91
Sell
41
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 22.34 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 22.34 while PTGX 8-day exponential moving average is 21.79, which is a Buy signal.
- The stock price of PTGX is 22.34 while Protagonist Therapeutics 20-day EMA is 21.14, which makes it a Buy.
- Protagonist Therapeutics 50-day exponential moving average is 18.21 while PTGX share price is 22.34, making it a Buy technically.
- PTGX stock price is 22.34 and Protagonist Therapeutics 200-day simple moving average is 14.61, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.32 per share, and an increase next year of $0.17 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is 1.21, suggesting Protagonist Therapeutics is a Buy
- Protagonist Therapeutics Relative Strength Index (RSI) is 59.37, which suggest Protagonist Therapeutics is overbought
- The Bollinger Bands (25) for Protagonist Therapeutics is (17.21 - 24.21), which suggest Protagonist Therapeutics is a Buy
- The Bollinger Bands (100) for Protagonist Therapeutics is (8.1 - 18.64), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.